Hangzhou, China

Fang Hu

This inventor holds 8 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Hangzhou Converd Co., Ltd., Hangzhou Converd Co., Ltd., Hangzhou Convero Co., Ltd.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fang Hu. Retrieved from https://idiyas.com/inventor/fang-hu-i6m07buv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

 

Average Co-Inventor Count = 4.4

ph-index = 1


Location History:

  • Zhejiang, CN (2021 - 2023)
  • Hangzhou, CN (2022 - 2023)

Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **The Innovations of Inventor Fang Hu**

Introduction

Fang Hu is a renowned inventor based in Hangzhou, China, known for his groundbreaking contributions to the field of therapeutic agents. With a total of seven patents to his name, his work particularly focuses on novel approaches to cancer treatment through the development of nucleic acids and immune cell modifications.

Latest Patents

Fang Hu's latest patents reflect his innovative spirit and dedication to improving therapeutic methods. His first notable patent, titled "Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and uses thereof," describes a therapeutic agent that includes a nucleic acid designed for introduction into tumor and cancer cells. This patent highlights a sophisticated mechanism involving a labeling polypeptide that creates modifications on the cell surfaces, allowing for targeted treatment.

Additionally, his patent "Therapeutic agents comprising nucleic acids and TCR modified immune cells and uses thereof," involves a combination of nucleic acids and T-cell receptor modified immune cells. This invention significantly enhances the recognition and binding to specific epitopes presented by MHC class I molecules, providing a promising new route for tumor treatment through synergistic effects.

Career Highlights

Fang Hu's career features significant involvement with Hangzhou Converd Co., Ltd., where he has played an integral role in the development of innovative biotherapeutics. His expertise and pioneering efforts have established him as a key figure in advancing cancer therapeutics aimed at improving patient outcomes.

Collaborations

Throughout his career, Fang Hu has collaborated with distinguished professionals such as Ronghua Zhao and Jipo Sheng. These collaborations have been instrumental in fostering a nurturing environment for creativity and scientific advancement, further enhancing the impact of his inventions in the medical field.

Conclusion

Fang Hu stands out as an influential inventor with a focus on innovative therapeutic solutions targeting cancer treatment. His contributions are critical not only in advancing medical science but also in inspiring future innovations in the field. With ongoing research and development, Fang Hu continues to pave the way for new discoveries that have the potential to revolutionize cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…